ArticleCureus2026
Aneurysmal Subarachnoid Hemorrhage in Pediatric DADA2: A Case Report and Literature Review.
Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Deficiency of adenosine deaminase 2 (DADA2) is a rare autosomal recessive autoinflammatory vasculopathy frequently associated with early-onset central nervous system involvement. Intracranial aneurysm formation and aneurysmal subarachnoid hemorrhage (aSAH) represent uncommon manifestations and remain poorly characterized from a neuroradiological perspective. We report the case of a nine-year-old boy with genetically confirmed DADA2 presenting with aneurysmal subarachnoid hemorrhage who underwent multimodal neurovascular imaging, including digital subtraction angiography (DSA). To contextualize this finding, a structured literature review was performed to identify previously reported cases of intracranial aneurysms in patients with genetically confirmed DADA2. Clinical presentation, hemorrhagic phenotype, aneurysm location, and treatment strategies were analyzed. In addition to our case, seven published patients with genetically confirmed DADA2 and intracranial aneurysms were identified, yielding a total of eight analyzed patients. Hemorrhagic events occurred in five of the eight patients, whereas three of the eight patients presented exclusively with ischemic manifestations. Aneurysms were predominantly multiple and located in the posterior circulation or distal vessels. Anti-TNF-α therapy was administered in seven patients, while aneurysm-directed intervention was reported in one case. These findings suggest that DADA2-associated aneurysms represent a distinct inflammatory neurovascular phenotype characterized by multiplicity and peripheral distribution. In pediatric patients presenting with unexplained aneurysmal subarachnoid hemorrhage, particularly in the context of systemic inflammatory features, DADA2 should be considered as a potential underlying etiology. Comprehensive vascular assessment with DSA may be essential for detecting small or atypically located aneurysms in this setting.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.